Another mechanism through which exendin-4 increases BMD is reducing the expression of SOST/sclerostin in MLO-Y4 cells, which leads to increased serum levels of osteocalcin, decreased serum levels of sclerostin and increased femoral BMD in T2D rats [46]. Here, BGLAP is linked to type 2 diabetes mellitus.